on 23 Nov 2021
Last Applicant/ Owned by
5959 Horton Street, Suite 300
Emeryville
CA
94608
Serial Number
87748380 filed on 09th Jan 2018
Registration Number
6569577 registered on 23rd Nov 2021
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
Providing temporary use of on-line nondownloadable software and applications for genome analysis, developing personal treatment strategies for patients with diagnosed cancer; conducting early evaluations in the field of pharmaceuticals; consulting services in the fields of biotechnology and pharmaceutical research; pharmaceutical product development and evaluation services; pharmaceutical research Read More
healthcare
18th Mar 2019
18th Mar 2019
Providing temporary use of on-line nondownloadable software and applications for genome analysis, developing personal treatment strategies for patients with diagnosed cancer; conducting early evaluations in the field of pharmaceuticals; consulting services in the fields of biotechnology and pharmaceutical research; pharmaceutical product development and evaluation services; pharmaceutical research and development; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; research and development of pharmaceuticals for the treatment of cancer; research and development of vaccines and medicines; technical research in the field of pharmaceutical studies; development of platform technology, namely, cancer immunotherapy platforms for manufacturing therapeutics; conducting clinical trials for others in the field of pharmaceuticals for the treatment and prevention of cancer; consulting services for others in the field of design, planning, and implementation of clinical trials; scientific research services, namely, collection of specific molecular and genomic data for analytical and clinical purposes, for the treatment of cancer and other diseases and disorders and for individuals' responses to drug treatments; providing scientific advice in the fields of cancer biology, cancer treatment, pharmaceutical side effects, genomics, cancer medicine and translational medicine; providing scientific analysis in the field of next generation sequencing (NGS), namely, the analysis and interpretation of genomic data obtained from cancer patients; providing an online, non-downloadable computer software platform for purposes of storing and providing information about an individual's cancer profile and genomic changes to enable physicians and healthcare professionals to optimize treatment in clinical practice
17th Sep 2016
17th Sep 2016
next-generation sequencing (NGS) data processor; bioinformatics data processor; downloadable computer software for genome analysis, developing personal treatment strategies for patients with diagnosed cancer, analyzing, screening, identifying, quantifying, and interpreting data in the field of mass spectrometry
17th Sep 2016
17th Sep 2016
pharmaceutical preparations for the treatment of cancer; anti-cancer preparations; vaccines; vaccine preparations
18th Mar 2019
18th Mar 2019
No 87748380
No Service Mark
No GRITST.001TM
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
26th Dec 2023 | COUNTERCLAIM OPP. NO. 999999 |
23rd Nov 2021 | REGISTERED-PRINCIPAL REGISTER |
21st Oct 2021 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
21st Oct 2021 | TEAS POST PUBLICATION AMENDMENT RECEIVED |
20th Oct 2021 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
18th Oct 2021 | STATEMENT OF USE PROCESSING COMPLETE |
15th Oct 2021 | TEAS STATEMENT OF USE RECEIVED |
15th Oct 2021 | USE AMENDMENT FILED |
23rd Jun 2021 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
17th Jun 2021 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |